Johnson & Johnson announced it plans to separate its consumer health products into a separate company, leaving the remaining business to focus on the more research-oriented pharmaceuticals and medical devices business segments. The announcement follows similar moves made by other large pharmaceutical and medical device companies.
Mr. Alex Gorsky needs to provide a more reasoned explanation for his decision to remain on President Trump's American Manufacturing Council and what he can achieve even as five CEOs have departed following Mr. Trump's response to Charlottesville.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Life sciences executives and managers got an exclusive peek into the thinking of Johnson & Johnson’s (NYSE:JNJ) next CEO last week, but those who heard Alex Gorsky speak had idea at the time. Gorsky was introduced to the nearly 1,000 attendees of the CED Life Science Conference in Raleigh, North Carolina as vice chairman of […]